The AI Economy Reshapes Opportunity BlueCollar Trades Gain Favor as WhiteCollar Entry Roles Slow Genpact CEO Warns AI Will Reduce IT Workload and Jobs Demands Higher Skill Sets Micron Technology Surpasses 1 Trillion Market Cap Following UBS Price Target Upgrade Summer Electricity Costs Set to Surge as Heat Waves and Rising Rates Collide ET Alpha Wealth Summit Leading Investors to Chart Indias Investment Roadmap for the Next Decade Ferrari Debuts First Fully Electric Model Luce Amid Market Scrutiny Heidmar Maritime Holdings Corp HMR Q4 2025 Earnings EPS Misses Estimates Sharply Yet Stock Surges Over 29 FrontView REIT Q1 2026 Earnings EPS Surges Past Estimates with 174 Surprise Energy Transfer ET Q1 2026 Earnings Mixed Results with EPS Miss but Slight Stock Uptick KVH Industries Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Slightly ACGLO Q1 2026 Earnings EPS Misses Estimates Amid Mixed Underwriting Conditions Enerflex Ltd EFXT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Progress Software PRGS Slides 097 as Resistance Holds Firm CMSD Edges Higher Amid Steady Income Demand Technical Levels in Focus Heartbeam Inc Warrant BEATW Surges 1077 as Trading Intensifies Near Key Level Triple Flag Precious Metals TFPM Slips 36 Approaches Key Support at 292 Cerence Inc CRNC Gains 328 Testing Resistance Near 12 Nuveen Variable Rate Preferred Income Fund NPFD Edges Higher Amid Steady Demand Roadzen Inc Warrants RDZNW Fall Sharply as Selling Pressure Intensifies Silexion Therapeutics Warrants SLXNW Hold Steady at 002 Amid Thin Trading Profusa Inc PFSA Slides 47 as Stock Tests Key Support at 033 CorMedix Inc CRMD Edges Lower as Stock Tests Key Support Near 758 Orchestra BioMed OBIO Edges Higher Navigating Key Support and Resistance Levels Alibaba Unveils NextGeneration Zhenwu AI Chip and Large Language Model Bolstering Cloud AI Portfolio CPRI Q1 2026 Earnings EPS Surges 93 Above Estimates Shares Rally Novanta NOVT Slips 135 as Stock Tests Key Support Levels VALU Q1 2026 Earnings EPS of 069 Amid Market Headwinds RDNW Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues HMR Q1 2026 Earnings EPS Beats Estimates by Over 1000 but Stock Tumbles 20 XYL Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick APYX Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid Revenue Uncertainty NRSN Q2 2025 Earnings Narrower Loss Surprises Shares Gain on Cost Discipline